Haemonetics shares jump on expanded plasma device rollout
Haemonetics said it is expanding the rollout of plasma collection devices, with its stock up 17% to $119.56, on pace for its highest close since $116.97.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Haemonetics said it is expanding the rollout of plasma collection devices, with its stock up 17% to $119.56, on pace for its highest close since $116.97.
Haemonetics (NYSE: HAE ) released first-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary Haemonetics C